Pairing advanced LED innovation with our sensorial, results-driven formulations to optimise visible skin results, the Red Light Mask perfectly reflects Elemis’ high-touch, high-tech philosophy. – Angela Taylor, global director of education

Elemis has branched into LED skincare with the launch of its breakthrough Red Light Mask. Now available as a professional treatment add-on and at-home solution, the age-defying light therapy device offers triple-action wavelength power, clinically proven results and an optimised design and fit.

Demand for LED skincare is rising fast – and with its philosophy of high-tech, high-touch treatments, Elemis is leveraging its reputation for results-driven products. With searches for ‘LED mask’ up 57 per cent globally in the past year (Wgsn.com, 2026) and 60 per cent of consumers looking for solutions to support natural ageing (McKinsey, 2025) and searches for ‘notox’ have risen by 34 per cent (Wgsn.com, 2025), the new Red Light Mask offers a timely and exciting opportunity for both spas and retailers.

With just 10 minutes of consistent use, the mask is clinically proven to reveal a brighter, smoother and rejuvenated complexion.* And the technology is impressive: precision-engineered diodes create 100 per cent uniform light coverage, while wavelengths of 630 nanometres (nm), 830nm and 1070nm can penetrate skin at different depths. Made with medical-grade silicone for an optimised fit, this professional-level treatment will visibly improve the appearance of brightness, smoothness and redness.

Angela Taylor, global director of education at Elemis, said: “We’re so excited to launch the Elemis Red Light Mask, both as an at-home ritual for our customers and to elevate our professional treatment experiences. Pairing advanced LED innovation with our sensorial, results-driven formulations to optimise visible skin results, it perfectly reflects Elemis’ high-touch, high-tech philosophy.”

The Elemis Red Light Mask retails for £350 (US$445, €410).

For further details, please reach out to [email protected]

*iSmart Clinical Study Document (0001-Rep-001), 2019. Results based on 25 people over 4 weeks and iSmart Study_0001-Rep-002, 2020. Results based on 19 people over 4 weeks.